University of Colorado, Denver
RATIONALE: Studying samples of sputum and tissue in the laboratory from patients with dysplasia or cancer may help doctors identify and learn more about biomarkers related to cancer. It may also help the study of cancer in the future. PURPOSE: This laboratory study is looking at biomarkers in patients with respiratory tract dysplasia or lung cancer, head and neck cancer, or aerodigestive tract cancer.
OBJECTIVES: Primary * Determine intermediate biomarkers of premalignant respiratory epithelial lesions, such as genetic mutations or altered growth factor expression, in patients with dysplasia of the respiratory epithelium or lung cancer, head and neck cancer, or aerodigestive tract cancer. Secondary * Establish a tissue repository of normal and dysplastic respiratory epithelium from endobronchial forceps and brush biopsy tissue from these patients and from normal volunteers. OUTLINE: Patients are stratified according to presence of extensive and severe dysplasia of the respiratory epith…
Inclusion Criteria: Two broad patient groups are of interest: those with extensive and severe dysplasia of the respiratory epithelium and those without dysplasia of the respiratory epithelium. The patients with dysplasia will be recruited from the following: * Individuals identified through the SPORE Tissue Procurement Screening Project with moderate or severe dysplasia. * Patients identified by private and academic physicians with moderate or severe dysplasia on cytology. * One year or greater survivors of one or more aerodigestive system carcinomas. * Patients with head and neck cancers wh…
Laboratory test
Laboratory Test
Laboratory Test
Laboratory Test
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.